Lord's Mark Industries Secures MHRA Registration for IVD Portfolio, Plans UK Expansion
Lord's Mark Industries has secured UK Medicines and Healthcare products Regulatory Agency (MHRA) registration for its In-Vitro Diagnostic (IVD) portfolio, following its recent approval for an AI-powered haemodialysis system. The company plans to begin commercial sales of its IVD products in the UK by December 2026, ahead of schedule, and launch a pathology laboratory in January 2027. These steps aim to expand its healthcare and diagnostics presence across the UK and allied markets, integrating product exports with healthcare delivery services.
First-hand measurement across 4 sources
We measured how 4 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 38/100.
Outlets measured: news18, indiatvnews, businessstandard, thetribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thetribune broke this story on 5 Oct, 07:20 am. Other outlets followed.